Diagnostic and Statistical Manual: Difference between revisions

From ProleWiki, the proletarian encyclopedia
mNo edit summary
Line 8: Line 8:


===Financial conflicts of interest===
===Financial conflicts of interest===
A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.<ref name='10.1159/000091772'>{{Citation|doi=10.1159/000091772|author=Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.|year=2006|title=Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry|journal=Psychotherapy and Psychosomatics|volume=75(3f)|page=154–160}}</ref>
A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.<ref name='10.1159/000091772'>{{Citation|doi=10.1159/000091772|author=Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.|year=2006|title=Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry|journal=Psychotherapy and Psychosomatics|volume=75(3)|page=154–160}}</ref>
   
   
[[Category:Psychiatry]]
[[Category:Psychiatry]]

Revision as of 15:14, 4 November 2022

The Diagnostic and Statistical Manual of Mental Disorders (abbreviation: DSM) is a publication of works that classify psychiatric disorders. The DSM is created and published by the American Psychiatric Association.

Criticisms

There are a number of different criticisms that have been leveled against the DSM and its usefulness as a diagnostic manual.

Lack of Objective Analysis

The DSM does not require the use of objective analysis.

Financial conflicts of interest

A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.[1]

  1. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry. Psychotherapy and Psychosomatics, vol.75(3) (pp. 154–160). doi: 10.1159/000091772 [HUB]